Accretion Nutrav

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1KVQ01019
  • NSEID:
  • BSEID: 544694
INR
193.90
13.85 (7.69%)
BSENSE

Mar 25

BSE+NSE Vol: 11000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039945,
    "name": "Accretion Nutrav",
    "stock_name": "Accretion Nutrav",
    "full_name": "Accretion Nutraveda Ltd",
    "name_url": "stocks-analysis/accretion-nutrav",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "193.90",
    "chg": 13.85,
    "chgp": "7.69%",
    "dir": 1,
    "prev_price": "180.05",
    "mcapval": "141.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544694,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE1KVQ01019",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": 11000,
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/accretion-nutrav-10039945-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039945",
    "stock_news_url": "https://www.marketsmojo.com/news/accretion-nutraveda-10039945"
  },
  "announcements": [
    {
      "caption": "Clarification On Price Movement",
      "datetime": "20-Feb-2026",
      "details": "Please find enclosed herewith clarification letter on Price Movement",
      "source": "BSE"
    },
    {
      "caption": "Clarification sought from Accretion Nutraveda Ltd",
      "datetime": "19-Feb-2026",
      "details": "The Exchange has sought clarification from Accretion Nutraveda Ltd on February 19 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "17-Feb-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Unicorn Fund",
      "source": "BSE"
    }
  ],
  "corporate_actions": []
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Clarification On Price Movement

20-Feb-2026 | Source : BSE

Please find enclosed herewith clarification letter on Price Movement

Clarification sought from Accretion Nutraveda Ltd

19-Feb-2026 | Source : BSE

The Exchange has sought clarification from Accretion Nutraveda Ltd on February 19 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

The reply is awaited.

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

17-Feb-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Unicorn Fund

stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available